Intellectual Property

Federal Court of Appeal rejects ‘novel argument’ for remedy in patent infringement

Tuesday, February 20, 2018 @ 11:29 AM | By Amanda Jerome

An argument of remedy for patent infringement brought by Apotex Inc. against Bayer Inc. at the Federal Court of Appeal is being called novel and innovative by patent lawyers, but not...

To view the full article, Click Here to Subscribe
or sign up for a 14-day FREE Trial

Already a subscriber? Click here to sign in

Featured

Chief Justice of British Columbia Robert Bauman

Ottawa ‘saves’ millions by making tardy judicial appointments; average delay 11 months in 2023

Latest

Business Canada signs Ukraine free-trade deal, sanctions illegal transfer of Ukrainian kids to Russia

Business Federal Court dismisses application to withhold information sought under Access to Information Act

Civil Litigation Court denies developer’s appeal to not pay road improvement costs

Civil Litigation Court dismisses extension to appeal where unit owner owed over $300K in levies

Personal Injury Judge erred in refusing to grant leave to amend statement of claim against Bayer Inc., court rules